2022
Juxta-papillary duodenal diverticula are associated with pyogenic liver abscesses: a case control study
Shankar U, Bhandari P, Panchal A, Weeks D, Wu H, Chen F, Maheshwari N, Bansal R, Walfish A, Baum J, Jamidar PA, Aron J. Juxta-papillary duodenal diverticula are associated with pyogenic liver abscesses: a case control study. BMC Gastroenterology 2022, 22: 52. PMID: 35130860, PMCID: PMC8822858, DOI: 10.1186/s12876-022-02120-4.Peer-Reviewed Original ResearchConceptsRisk factorsCryptogenic PLADiabetes mellitusDuodenal diverticulumLiver abscessesOdds ratioSignificant associationMultiple logistic regression analysisConcurrent acute cholecystitisCryptogenic liver abscessesPyogenic liver abscessesIdentifiable risk factorsRetrospective chart reviewThird of patientsTraditional risk factorsCase-control studyStudy inclusion criteriaDiagnosis of PLAMultiple logistic regressionLogistic regression analysisUnidentified risk factorsElectronic medical recordsComputerized tomography (CT) imagingSingle expert radiologistAscending cholangitis
2020
Musculoskeletal Pain Symptoms and Injuries Among Endoscopists Who Perform ERCP
Campbell EV, Muniraj T, Aslanian HR, Laine L, Jamidar P. Musculoskeletal Pain Symptoms and Injuries Among Endoscopists Who Perform ERCP. Digestive Diseases And Sciences 2020, 66: 56-62. PMID: 32144599, DOI: 10.1007/s10620-020-06163-z.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyMusculoskeletal pain symptomsPain symptomsRisk factorsMusculoskeletal injuriesPrevalent musculoskeletal injuriesDe Quervain's tenosynovitisPotential risk factorsRisk of injuryAnonymous electronic surveyNeck painBack painQuervain's tenosynovitisRetrograde cholangiopancreatographyResultsA totalPreventative strategiesConclusionsThe majorityInjurySymptomsEndoscopistsProtective gearMultiple studiesHalf reportTenosynovitisElectronic survey
2015
Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview
Rustagi T, Jamidar PA. Endoscopic Retrograde Cholangiopancreatography–Related Adverse Events General Overview. Gastrointestinal Endoscopy Clinics Of North America 2015, 25: 97-106. PMID: 25442961, DOI: 10.1016/j.giec.2014.09.005.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyAdverse eventsRetrograde cholangiopancreatographyERCP-related adverse eventsProcedure-related risk factorsOverall adverse event rateAdverse event ratesManagement of patientsPost-ERCP pancreatitisRoutine endoscopic proceduresRisk factorsPancreaticobiliary diseasesEndoscopic proceduresEvent ratesCholangiopancreatographyMonumental advancesInherent risksHigher inherent riskBleedingPancreatitisSedationPatientsInfectionDiseaseDiagnosis
2014
Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features
Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part I: Epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Disease-a-Month 2014, 60: 530-550. PMID: 25510320, DOI: 10.1016/j.disamonth.2014.11.002.Peer-Reviewed Original Research
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence
1996
Pancreatitis complicating endoscopic biliary sphincterotomy (ES): A prospective multivariate analysis of risk factors including pancreatic sphincter hypertension (PSH)
Freeman M, Mallery S, Sherman S, Jamidar P, Silverman W, Ryan M, Cunningham J, Haber G, Herman M, Nelson D. Pancreatitis complicating endoscopic biliary sphincterotomy (ES): A prospective multivariate analysis of risk factors including pancreatic sphincter hypertension (PSH). Gastrointestinal Endoscopy 1996, 43: 381. DOI: 10.1016/s0016-5107(96)80361-0.Peer-Reviewed Original Research
1993
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients
Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, Hawes R, Lehman G. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointestinal Endoscopy 1993, 39: 652-657. PMID: 8224687, DOI: 10.1016/s0016-5107(93)70217-5.Peer-Reviewed Original ResearchConceptsHigh-risk patientsMain pancreatic ductSmaller common bile duct diameterCommon bile duct diameterBile duct diameterStent groupEndoscopic sphincterotomyPancreatic ductDuct diameterIncidence of pancreatitisIndependent risk factorPre-cut sphincterotomyOddi dysfunctionProphylactic stentingHospital daysCommon complicationPapillary edemaSevere pancreatitisBiliary sphincterotomyStent placementRisk factorsProspective fashionSphincterotomyPancreatitisPatients